ℹ️ Compiled from public regulatory records · Last regulator revision: March 27, 2026🚩 Report this page
Lormetazepam
Benzodiazepine Derivatives
GB MHRA
- Drug class
- Benzodiazepine Derivatives
- Availability
- See label
- Markets covered
- 1
- Products on record
- 6
Overview
Lormetazepam is an active pharmaceutical ingredient in the Benzodiazepine Derivatives group (N05CD). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 6 | March 27, 2026 |
GBUnited Kingdom· MHRA
6 products
6 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Sources & citations
- [1]MHRA (UK) · PLPI187992217 · revised June 6, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.